These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8422814)

  • 21. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia].
    Tong N; Liang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):409-11. PubMed ID: 1814823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.
    Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T
    Diabetes Care; 1996 Feb; 19(2):151-6. PubMed ID: 8718436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia.
    McLaughlin T; Abbasi F; Lamendola C; Leary E; Reaven GM
    Metabolism; 2002 Oct; 51(10):1355-9. PubMed ID: 12370858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.
    Kashi Z; Mahrooz A; Kianmehr A; Alizadeh A
    PLoS One; 2016; 11(3):e0151543. PubMed ID: 26978661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control.
    Shih KC; Kwok CF; Hwu CM; Hsiao LC; Li SH; Liu YF; Ho LT
    Diabetes Res Clin Pract; 1997 May; 36(2):113-9. PubMed ID: 9229195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.
    Brussaard HE; Gevers Leuven JA; Frölich M; Kluft C; Krans HM
    Diabetologia; 1997 Jul; 40(7):843-9. PubMed ID: 9243107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
    Avogaro A; Beltramello P; Marin R; Zambon S; Bonanome A; Biffanti S; Confortin L; Manzato E; Crepaldi G; Tiengo A
    Atherosclerosis; 1995 Feb; 113(1):117-24. PubMed ID: 7755647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.
    Koskinen P; Mänttäri M; Manninen V; Huttunen JK; Heinonen OP; Frick MH
    Diabetes Care; 1992 Jul; 15(7):820-5. PubMed ID: 1516498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL; Stewart J; Issa M; Lake B; Melis R
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM.
    Garg A; Grundy SM
    Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.
    Hoffmann J; Spengler M
    Am J Med; 1997 Dec; 103(6):483-90. PubMed ID: 9428831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different insulin regimens in elderly patients with NIDDM.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
    Coniff RF; Shapiro JA; Robbins D; Kleinfield R; Seaton TB; Beisswenger P; McGill JB
    Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
    Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.